Importantly, since CF clinical outcomes are only partially determined by CFTR mutations and are influenced by other genetic modifiers, as shown in previous studies58-61, this highlights the potential of Drosophila for investigating CF genetic modifiers—especially those that are challenging to study at scale in other CF models. Here, CFTR is linked to cystic fibrosis.